•  Nitric Oxide
  •  Products
  •  Innovation
  •  Investors
  •  Connect

Nu-Med Plus

  •  Nitric Oxide
  •  Products
  •  Innovation
  •  Investors
  •  Connect

Nu-Med Plus, Inc. Selects Salient Technologies, Inc. for Go to Market Design of Nitric Oxide Medical Device for FDA Submission

Posted on October 3, 2017June 14, 2019
Posted in Investor News

Post navigation

Nu-Med Plus Inc. Announces Patent Approval Notification For Low Cost Nitric Oxide Technology
Franklin Innovation joins Nu-Med Plus development team for FDA submission of Nitric Oxide Hospital Medical Device

Connect

Jeff Robins | CEO
jeff@nu-medplus.com
801.746.3570
LinkedIn
Twitter

Offices

Corporate 455 E. 500 S.
Suite #203
Salt Lake City UT, 84111

Lab 1266 S 1380 W
Orem UT, 84111

News

Stay Up to Date On Nu-Med Plus News

Legal

SEC Documents Shareholder Letters Privacy Policy

Crunchbase

Profile

© 2021 Nu-Med Plus All Rights Reserved

Site designed + built by Wildern